Ironwood Non Current Liabilities Total from 2010 to 2024

IRWD Stock  USD 8.12  0.18  2.17%   
Ironwood Pharmaceuticals' Non Current Liabilities Total is increasing over the years with slightly volatile fluctuation. Non Current Liabilities Total is expected to dwindle to about 370.6 M. During the period from 2010 to 2024 Ironwood Pharmaceuticals Non Current Liabilities Total annual values regression line had geometric mean of  274,504,482 and mean square error of 18126.9 T. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
2008-12-31
Previous Quarter
569.2 M
Current Value
541.3 M
Quarterly Volatility
191.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ironwood Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ironwood main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Interest Expense of 19.9 M or Total Revenue of 231.7 M, as well as many exotic indicators such as Price To Sales Ratio of 3.82, Dividend Yield of 0.0 or Days Sales Outstanding of 142. Ironwood financial statements analysis is a perfect complement when working with Ironwood Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Ironwood Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Ironwood Pharmaceuticals Technical models . Check out the analysis of Ironwood Pharmaceuticals Correlation against competitors.
For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.

Latest Ironwood Pharmaceuticals' Non Current Liabilities Total Growth Pattern

Below is the plot of the Non Current Liabilities Total of Ironwood Pharmaceuticals over the last few years. It is Ironwood Pharmaceuticals' Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ironwood Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total10 Years Trend
Slightly volatile
   Non Current Liabilities Total   
       Timeline  

Ironwood Non Current Liabilities Total Regression Statistics

Arithmetic Mean352,288,593
Geometric Mean274,504,482
Coefficient Of Variation48.48
Mean Deviation137,076,129
Median408,897,000
Standard Deviation170,795,678
Sample Variance29171.2T
Range521.1M
R-Value0.65
Mean Square Error18126.9T
R-Squared0.42
Significance0.01
Slope24,838,562
Total Sum of Squares408396.3T

Ironwood Non Current Liabilities Total History

2024370.6 M
2023541.3 M
2022422.6 M
2021359.3 M
2020463.9 M
2019455.1 M
2018408.9 M

About Ironwood Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Ironwood Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Ironwood Pharmaceuticals investors use historical funamental indicators, such as Ironwood Pharmaceuticals's Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Although Ironwood Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Ironwood Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ironwood Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ironwood Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ironwood Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Current Liabilities Total541.3 M370.6 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Ironwood Pharmaceuticals is a strong investment it is important to analyze Ironwood Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ironwood Pharmaceuticals' future performance. For an informed investment choice regarding Ironwood Stock, refer to the following important reports:
Check out the analysis of Ironwood Pharmaceuticals Correlation against competitors.
For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Ironwood Stock analysis

When running Ironwood Pharmaceuticals' price analysis, check to measure Ironwood Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ironwood Pharmaceuticals is operating at the current time. Most of Ironwood Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ironwood Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ironwood Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ironwood Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Managers
Screen money managers from public funds and ETFs managed around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Is Ironwood Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ironwood Pharmaceuticals. If investors know Ironwood will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ironwood Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.69)
Earnings Share
(6.45)
Revenue Per Share
2.848
Quarterly Revenue Growth
0.097
Return On Assets
0.1339
The market value of Ironwood Pharmaceuticals is measured differently than its book value, which is the value of Ironwood that is recorded on the company's balance sheet. Investors also form their own opinion of Ironwood Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ironwood Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ironwood Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ironwood Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ironwood Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ironwood Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ironwood Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.